Jiangxi Fushine Pharmaceutical Co., Ltd.

XSEC:300497 Stock Report

Market Cap: CN¥6.5b

Jiangxi Fushine Pharmaceutical Balance Sheet Health

Financial Health criteria checks 3/6

Jiangxi Fushine Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 67.8%. Its total assets and total liabilities are CN¥4.6B and CN¥2.3B respectively.

Key information

67.8%

Debt to equity ratio

CN¥1.62b

Debt

Interest coverage ration/a
CashCN¥676.89m
EquityCN¥2.39b
Total liabilitiesCN¥2.26b
Total assetsCN¥4.65b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300497's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.5B).

Long Term Liabilities: 300497's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥808.9M).


Debt to Equity History and Analysis

Debt Level: 300497's net debt to equity ratio (39.4%) is considered satisfactory.

Reducing Debt: 300497's debt to equity ratio has increased from 60.8% to 67.8% over the past 5 years.

Debt Coverage: 300497's debt is not well covered by operating cash flow (6.3%).

Interest Coverage: Insufficient data to determine if 300497's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies